clinical trial · NCT00368641
Heart Failure and Peritoneal Ultrafiltration
Vantive Health LLC·phase2·terminated·n = 12
Congestive Heart FailureExtraneal
brief summary
The objective of the study is to determine if the addition of peritoneal ultrafiltration to standard therapy in treatment-resistant severe heart failure patients will improve fluid balance and functional capacity such that they will spend less time in the hospital and have an improved ambulatory quality of life in comparison to patients who remain on standard therapy alone.
started
Aug 1, 2006
primary completion
Apr 1, 2008
completion
Apr 1, 2008
last updated
Jul 15, 2025
official title
Treatment-Resistant Heart Failure (HF) and Peritoneal Ultrafiltration (PUF): A Randomized Prospective Trial of Standard Care Versus Standard Care With Peritoneal Ultrafiltration in Patients With Treatment-Resistant Severe Heart Failure
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol